<?xml version="1.0" encoding="UTF-8"?>
<p>There are only few case reports and small studies showing that HBVr can occur with TCZ therapy in patients with chronic HBV infection without antiviral prophylaxis.
 <sup>
  <xref rid="bibr25-1759720X20912646" ref-type="bibr">25</xref>,
  <xref rid="bibr83-1759720X20912646" ref-type="bibr">83</xref>
  <xref rid="bibr84-1759720X20912646" ref-type="bibr"/>
  <xref rid="bibr85-1759720X20912646" ref-type="bibr"/>â€“
  <xref rid="bibr86-1759720X20912646" ref-type="bibr">86</xref>
 </sup> In all published data, the use of antivirals prevented HBVr in this setting. In rheumatic patients with resolved infection, HBVr is rare,
 <sup>
  <xref rid="bibr58-1759720X20912646" ref-type="bibr">58</xref>,
  <xref rid="bibr87-1759720X20912646" ref-type="bibr">87</xref>
 </sup> and has been reported only in the form of transient HBV viremia.
 <sup>
  <xref rid="bibr37-1759720X20912646" ref-type="bibr">37</xref>,
  <xref rid="bibr88-1759720X20912646" ref-type="bibr">88</xref>
 </sup>
</p>
